[ad_1]
New York, October 20, 2020 (GLOBE NEWSWIRE) – Reportlinker.com Announces Release of Report “Kidney Disease Market Forecast to 2027 – Impact of COVID-19 and Global Analysis by Product Type; End User and Geography” – https: //www.reportlinker.com/p05978086/? utm_source = GNW
However, undiagnosed cases of kidney disease hamper market growth.
Chronic kidney disease (CKD) is a common and life-threatening condition that affects 1 in 10 people worldwide. High blood pressure and diabetes were the two leading causes in 75% of kidney failure cases between 2015 and 2017.
Furthermore, according to a study published by the National Kidney Foundation in 2020, around 35.0% of the diabetic population over the age of 20 would develop chronic kidney disease over the period of time.
According to data published by the National Kidney Foundation Inc., in 2020 CKD is likely to cause more deaths than prostate cancer or breast cancer. It is a poorly recognized emergency health condition among people. 1 in 3 American adults (approximately 80 million people) is at risk from CKD.
According to estimates given by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure could have chronic kidney disease. In 2015, 30.3 million people in the US had diabetes according to the American Diabetes Association. According to the CDC, in 2014, about 118,000 people in the U.S. began treatment for end-stage renal disease, and the number of people taking this treatment is expected to increase as more people realize that this condition. Additionally, the CDC states that about 96% of people with kidney damage are unaware that they have chronic kidney disease, indicating the underlying market outlook in the kidney disease market. These factors are expected to enhance market growth during the forecast period.
The global kidney disease market is segmented by product type and end user. According to the type of product, the market is segmented into diagnosis and treatment.
The diagnostic segment held the largest market share in 2019 and the same segment is forecast to record the highest CAGR in the market during the forecast period.In end-user terms, the kidney disease market has been segmented into hospitals, laboratories diagnostic and others.
The Saudi Center for Organ Transplantation, the South Australian Health and Medical Research Institute, the World Health Organization, the Agency for Pharmaceutical Products and Medical Devices, the European Medical Association, the World Trade Organization, Research and Pharmaceutical Manufacturers of America and the European Federation of Pharmaceutical Industries Associations are among the most important. secondary sources referenced in the preparation of this report.
Read the full report: https://www.reportlinker.com/p05978086/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can get all the market research you need, instantly, in one place.
__________________________
Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
